Feb 7 (Reuters) - Healius Ltd (HLS) :
- HAS NOT PUBLISHED A FORECAST FOR FY 2023 DUE TO UNPREDICTABILITY IN TRADING
- EXPECTS TRADING IN 2H 2023 TO BE MATERIALLY STRONGER THAN 1H 2023
- HY EBITDA A$182.0 MILLION VERSUS A$510.8 MILLION
- ALSO EXPECTS TO UNDERTAKE BETWEEN 1,000-2,000 COVID TESTS PER WORKING DAY
- HY REVENUE A$889.3 MILLION VERSUS A$1339.0 MILLION
- CASH PROCEEDS OF A$127 MILLION (BEFORE EARN-OUT) FROM DAY HOSPITALS SALE ARE EXPECTED TO BE RECEIVED AT END OF MARCH 2023
- EXPECTS TO REMAIN WITHIN ITS COVENANTS AT END OF FY 2023
- TAKING NON-CASH PRE-TAX IMPAIRMENT OF CIRCA A$39 MILLION RELATING TO 3RD PARTY GP MEDICAL CENTRE LEASES IN LUMUS IMAGING
News: HLS Healius Says Has Not Published Forecast For FY 2023 Due To Unpredictability In Trading
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
81.5¢ |
Change
-0.020(2.40%) |
Mkt cap ! $591.7M | |||
| Open | High | Low | Value | Volume |
| 81.0¢ | 83.0¢ | 78.0¢ | $4.121M | 5.071M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 75365 | 81.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 84.5¢ | 5500 | 1 |
View Market Depth
| Last trade - 16.10pm 12/08/2025 (20 minute delay) ? |
| HLS (ASX) Chart |